etoposide has been researched along with Antibody Deficiency Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohgaki, M; Bohgaki, T; Bristow, R; Cheung, P; El Ghamrasni, S; Eldin, MS; Guturi, KKN; Hakem, A; Hakem, R; Jeon, J; Kumareswaran, R; Ng, D; Patel, P; Raught, B; Srikumar, T; Stewart, GS | 1 |
| Inoue, M; Kawa, K; Koyama, M; Sawada, A; Yasui, M | 1 |
| Oliveira, BM; Rios Leite, VH; Silva, CM; Viana, MB | 1 |
3 other study(ies) available for etoposide and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chromosome Segregation; Craniofacial Abnormalities; DNA Topoisomerases, Type II; DNA, Catenated; Drug Resistance, Neoplasm; Etoposide; Fibroblasts; Gene Knockdown Techniques; HEK293 Cells; Humans; Immunologic Deficiency Syndromes; Learning Disabilities; Mice; Mutagenesis, Site-Directed; Neoplasms; Poly-ADP-Ribose Binding Proteins; Primary Immunodeficiency Diseases; Proteomics; RNA, Small Interfering; Topoisomerase II Inhibitors; Ubiquitin Thiolesterase; Ubiquitin-Protein Ligases; Ubiquitination | 2016 |
Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Lymphohistiocytosis, Hemophagocytic; Male; Remission Induction; Transplantation, Homologous | 2007 |
Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)
Topics: Child, Preschool; Drug Administration Schedule; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Immunologic Deficiency Syndromes; Infant; Langerhans Cells; Male; Recurrence; Remission Induction | 1991 |